From 2006-2018, 236 patients had a transvaginal rectocoele repair in our centre were identified. The data was not available for twenty-one patients and so these were excluded leaving 215 patients included in the analysis. The mean age for these was 55 years (range 30-81). 206 (95.8%) had previous vaginal deliveries, mean 2.4 (range 1-8). 86 (40%) patients had a hysterectomy, 61 (28.4%) had pelvic floor surgery and 35 (16.3%) had anal surgery.
The main complaint of this cohort of patients was ODS in 209 patients (97.2%) and feeling of vaginal prolapse/bulge in 175 patients (81.4%). Other symptoms present were various degree of anal incontinence (AI) in 119 patients (55.3%), faecal urgency in 104 (48.4%), need for vaginal splinting in 99 (46%) and anal digitation in 56 (26%), associated constipation in 39 (18.1%) and dyspareunia in 17 patients (7.9%). Concomitant urinary symptoms were present in 139 patients (67.9%).
In total, 86.5% of patients (186/215) underwent pre-operative conservative management and biofeedback, with a mean of sessions of 2.7 (SD 1.5, range 1-9). Of those, 82.8% (154/186) used suppositories, 49.5% (92/186) polyethylene glycol, 34.9% (65/186) used transanal irrigation, 17.7% (33/186) loperamide, 12.9% (24/182) ispaghula husk, 7% (13/186) prokinetic laxatives.
Regards surgical procedures, 98.1% (211/215) of patients had a levatorplasty at the time of the rectocoele repair and 19.5% (42/215) had an enterocoele repair. 27.4% (59/215) had a joint procedure with the urogynaecologists for urinary stress incontinence (tension-free vaginal tape TVTO), anterior or middle compartment prolapse. The mean length of hospital stay was 3.2 days (SD 1.2, range 2-10).
In terms of postoperative complications, 24 patients (11.2%) suffered from in-hospital complications. Of those, 18 (8.4%) with urinary retention and 2 (0.9%) with ileus, and 4 (1.9%) urinary tract infections. During follow up 14 patients (6.5%) had complications. Of those, 2 (0.9%) had urinary retention, 11 (5.1%) had vaginal infection and 1(0.5%) patient had to be re-admitted for a recto-vaginal fistula. Seven patients suffered from chronic pelvic pain (3.3%) and 17 (7.9%) with dyspareunia. 23 patients (10.7%) needed further pelvic floor surgery and 4 (1.9%) had a third pelvic floor procedure.
The mean length of follow up was 12.7 months (SD 13.9, range 1.4-71.5). Global improvement was reported in 189 (87.9%), 18 (8.4%) found that the procedure didn’t change their symptoms, while 8 (3.7%) have been lost on follow-up.
Furthermore, 67% of patients (144/215) agreed to continue conservative management after surgery, while 29.3% didn’t feel the need for further interventions (3.7% patients were lost on F/U) with a mean of 2.8 clinic sessions (SD 2.1, range 0-12), and 23.3% (50/215) needed to use transanal irrigation. Overall, 115 patients (53.5%) had residual symptoms, of which 50 (23.3%) were ODS, 32 (14.9%) were anal incontinence and 33 (15.3%) were mixed ODS/AI. Table 1 summarises the variations of the different types of symptoms after surgery. Excluding patients that had previous surgery or a combined procedure in the anterior pelvic floor compartment at the time of the transvaginal rectocoele repair, 46.3% (62/134) improved their initial urinary symptoms, 6.7% (9/134) developed de novo symptoms, 5.2% (7/134) had symptom deterioration and 1 patient (0.7%) didn’t change the initial symptomatology.